Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
1 The management of T2DM is becoming increasingly complex with the availability of more pharmacologic drug classes and the completion of high-quality clinical trials
Lifestyle factors interact with the pharmacokinetic curve to determine your actual experience
Acetazolamide for Monges disease: efficiency and tolerance of 6-month treatment
AstraZeneca is also planning to explore elecoglipron as a backbone for oral combinations (e.g., with dapagliflozin for T2DM/CKD/HF and with AZD0780 for dyslipidemia) to help differentiate in a rapidly evolving oral GLP-1 landscape.
Melatonin: the clinical perspective in man
US$ 27.84
US$ 28.75
US$ 21.30
